Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

VCU Massey Cancer Center researchers find new agent inhibits Leukemia cell survival

24.10.2005


A team of researchers at Virginia Commonwealth University Massey Cancer Center has discovered an entirely new mechanism of action for a novel pharmacological agent currently in clinical trials in patients – the kinase inhibitor BAY 43-9006 – which was designed to disrupt the survival pathways of tumor cells.



“This agent was originally designed to inhibit the Raf-1 pathway, which is frequently mutated in many types of cancers, including leukemia,” said Steven Grant, M.D., Massey’s principal investigator for the study that was published in the Oct. 21 issue of the Journal of Biological Chemistry. BAY 43-9006 is a new agent known to induce apoptosis, or cell death, in a variety of tumor cells, presumably by interrupting this pathway. The agent was made available to Massey’s researchers by the National Cancer Institute.

“We were surprised to find that the killing effects of Bay 43-9006 in human leukemia cells had very little to do with inhibition of the Raf-1 pathway,” Grant said. “Instead, the major mechanism of lethality of this compound involved down-regulation of a protein known as Mcl-1, which plays a critical role in protecting leukemic cells from apoptosis.


“What was even more interesting was that Bay 43-9006 appeared to reduce Mcl-1 levels by an unusual and unexpected mechanism-inhibition of the initiation of protein synthesis,” Grant said. “This insight into the mode of action of Bay 43-9006 could have important implications for the development of rational combination strategies involving this agent in leukemia and potentially other types of cancer.”

Grant is Massey’s associate director for translational research and co-leader of the cancer center’s cell-signaling program. He provides national leadership in hematologic malignancy research focused on finding new treatments for blood cancers such as leukemias, lymphomas and multiple myeloma. His work is funded by the National Cancer Institute, the V Foundation for Cancer Research, the Leukemia and Lymphoma Society of America and the Department of Defense.

The first author on the published paper with Grant was Mohamed Rahmani, Ph.D., VCU department of internal medicine/hematology-oncology.

Andrea Butler | EurekAlert!
Further information:
http://www.vcu.edu
http://www.vcu.edu/uns/Releases/2005/oct/102105a

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>